L

Lexicon Pharmaceuticals
D

LXRX

1.09500
USD
-0.03
(-2.67%)
مغلق
حجم التداول
40,676
الربح لكل سهم
-0
العائد الربحي
-
P/E
-2
حجم السوق
397,679,910
أصول ذات صلة
ABBV
ABBV
-0.465
(-0.24%)
190.325 USD
AMGN
AMGN
-2.01
(-0.65%)
306.66 USD
BMY
BMY
-0.525
(-1.07%)
48.455 USD
GSK
GSK
-0.250
(-0.65%)
37.965 USD
JNJ
JNJ
-1.240
(-0.73%)
168.350 USD
LLY
LLY
8.95
(1.11%)
812.95 USD
MRK
MRK
0.570
(0.68%)
84.730 USD
NVO
NVO
0.990
(1.40%)
71.720 USD
PFE
PFE
-0.555
(-2.19%)
24.810 USD
REGN
REGN
-1.20
(-0.21%)
563.22 USD
المزيد
الأخبار المقالات

العنوان: Lexicon Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.